Liver fibrosis in paediatric liver diseases
- PMID: 21497743
- DOI: 10.1016/j.bpg.2011.02.008
Liver fibrosis in paediatric liver diseases
Abstract
Numerous paediatric liver diseases from different origins may be complicated by development of liver fibrosis and progression to cirrhosis. Although fibrogenesis, which represents a major driving force for the development of liver fibrosis, has common tracts whatever the aetiology, liver fibrosis has different histopathological patterns in paediatric liver disease. In these diseases management choices may depend upon the stage of liver fibrosis. Thus, the accurate estimation of histological pattern of liver fibrosis is important for the prevention of the subsequent complications. Liver biopsy has long been considered as a gold standard diagnostic method for assessing liver fibrosis. However, due to its several disadvantages, in the last decades alternative and accurate non-invasive means to estimate fibrosis are developed. In this review, we characterised the most frequent histological patterns of liver fibrosis in paediatric liver diseases. Furthermore, we describe use of liver biopsy in diagnosis and staging of liver fibrosis, list the alternative non-invasive techniques that have an emerging role in the assessment of liver fibrosis, and propose a management algorithm.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
[Clinical application of non-invasive diagnosis for hepatic fibrosis].Korean J Hepatol. 2007 Jun;13(2):129-37. Korean J Hepatol. 2007. PMID: 17585186 Review. Korean.
-
Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.Liver Int. 2009 Jan;29 Suppl 1:19-22. doi: 10.1111/j.1478-3231.2008.01940.x. Liver Int. 2009. PMID: 19207962 Review.
-
Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.Best Pract Res Clin Gastroenterol. 2009;23(3):453-60. doi: 10.1016/j.bpg.2009.03.002. Best Pract Res Clin Gastroenterol. 2009. PMID: 19505671 Review.
-
Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):291-303. doi: 10.1016/j.bpg.2011.02.003. Best Pract Res Clin Gastroenterol. 2011. PMID: 21497746 Review.
-
Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology.Scand J Gastroenterol Suppl. 2006;(243):85-8. doi: 10.1080/00365520600664359. Scand J Gastroenterol Suppl. 2006. PMID: 16782627 Review.
Cited by
-
A Nomogram Predicting the Prognosis of Children With Biliary Atresia After Hepatoportoenterostomy.Front Pediatr. 2021 Feb 24;9:641318. doi: 10.3389/fped.2021.641318. eCollection 2021. Front Pediatr. 2021. PMID: 33718307 Free PMC article.
-
Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease.Sci Rep. 2018 Nov 13;8(1):16730. doi: 10.1038/s41598-018-34714-y. Sci Rep. 2018. PMID: 30425268 Free PMC article.
-
Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.PLoS One. 2015 May 21;10(5):e0127518. doi: 10.1371/journal.pone.0127518. eCollection 2015. PLoS One. 2015. PMID: 25996938 Free PMC article.
-
Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia.PLoS One. 2013 Nov 18;8(11):e80652. doi: 10.1371/journal.pone.0080652. eCollection 2013. PLoS One. 2013. PMID: 24260445 Free PMC article.
-
Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy.Clin Exp Pediatr. 2023 Mar;66(3):110-124. doi: 10.3345/cep.2022.00367. Epub 2022 Dec 19. Clin Exp Pediatr. 2023. PMID: 36550776 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical